Taiwan Pranlukast Market Size & Outlook, 2026-2034


Taiwan Pranlukast Market Insights

  • According to Reed Intelligence analysis, the Taiwan Pranlukast Market size was USD 6.57 Billion in 2025 and is projected to reach USD 15.07 Billion by 2034.
  • The Taiwan market is projected to grow at a CAGR of 9.71% between 2026 and 2034.
  • By segment, Tablets emerged as the largest Formulation Type in terms of market size in 2025.
  • Others is anticipated to remain the most attractive Formulation Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • As of 2025, Taiwan held 0.89% of the global Pranlukast Market size.
  • By 2034, United States is anticipated to capture the largest share of the global Pranlukast Market.
  • In Asia Pacific, China is expected to lead the regional Pranlukast Market size by 2034.
  • Taiwan will remain the fastest-growing market in Asia Pacific, reaching USD 15.13 Billion by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 6.57 Billion
Market Size In 2034 USD 15.07 Billion
Largest segment Tablets
Units Revenue in USD Billion
CAGR 9.71% (2026-2034)
Segmnetation Covered
Formulation Type
  1. Tablets
  2. Capsules
  3. Oral Suspensions
  4. Others
Application
  1. Asthma Treatment
  2. Allergic Rhinitis Treatment
  3. Bronchitis Management
  4. Others
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Drug Stores
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends